Page 30 of 32 · 749 questions tagged coa.
Numbers first: JEEP · Shanghai ERP Biotechnology. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
Numbers first: sampling plan · FGP. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
The particulars: method section · Homopeptide. I am at the decision point and I would rather think it through than improvise. I would rather spend money on…
Conditions: list of related substances · GGPeps. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan I…
The case in front of me: semaglutide · four weeks · 25 °C. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and…
The specifics, since they change the answer: 95.2% · chromatogram. I want to understand what this actually establishes, as opposed to what it is being used to imply.…
I have kept every message, invoice and document, which I gather is the useful habit. I would like to understand the steps well enough to explain them to someone else.…
Numbers first: SGN · a Karl Fischer water content test. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay this…
The particulars: PeptideMeter · Hunan Aslsen Technology. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am…
I have both a purity figure and a content figure, which is why the discrepancy is visible. I would like to define my thresholds before I have a result, for obvious…
This is a first order from this supplier, so I have no track record to reason from. I have read the primary source rather than the summary, which has left me with…
The case in front of me: HJ · Wuhan Wansheng Biotechnology. I would like the axes of comparison first and the recommendation second. I have tried the first option and…
Conditions: 97.1% · date of analysis. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result,…
The case in front of me: HJ · liraglutide. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and…
I have the plan documents and the written criteria, which took two calls to obtain. This is presented as though it settles something, and I am not convinced it does.…
Stated plainly: retatrutide · batch certificate. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
The particulars: GGPeps · ecnoglutide. I would like to know whether this claim survives contact with evidence. If the answer is "nobody has tested that", I would like…
Numbers first: 99.1% · lot-specific certificate. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
What I have: 98.2% · Janoshik · 96.8%. I have a result I cannot explain, and I would rather diagnose it than guess. I have checked the obvious explanations and…
What I have: mazdutide · sixteen weeks · 4 °C. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which…
Setup, so nobody has to ask: 96.8% · a C18 column · semaglutide. I would like help reading this properly rather than being told what conclusion to reach. I have the…
Numbers first: sampling plan · BCH. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Stated plainly: FGP · peptide mapping. The units are where I keep going wrong, so please be explicit about them. I have sanity-checked the order of magnitude and it…
The particulars: tirzepatide · chromatogram. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…